Corcept Therapeutics Inc
CORT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001088856
In the last 90 days, Corcept Therapeutics Inc insiders filed 0 open-market purchases and 21 sales; 424 institutions reported holding it in 13F filings for Q2 2026, worth $7.15B in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in Corcept Therapeutics Inc as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 321
- +37 vs. Q2 2024
- Shares held
- 88.5M
- +15.8M (+21.7%) vs. Q2 2024
- Total value
- $4.09B
- +$1.73B (+73.4%) vs. Q2 2024
- New holders
- 64
- 106 more added
- Sold out
- 27
- 106 more reduced
2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CORT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 424 | $7.15B |
| Q1 2026 | 352 | $3.20B |
| Q4 2025 | 390 | $2.67B |
| Q3 2025 | 429 | $6.41B |
| Q2 2025 | 422 | $5.79B |
| Q1 2025 | 422 | $9.24B |
| Q4 2024 | 368 | $4.25B |
| Q3 2024 | 321 | $4.09B |
| Q2 2024 | 286 | $2.90B |
| Q1 2024 | 285 | $2.36B |
| Q4 2023 | 274 | $2.75B |
| Q3 2023 | 247 | $2.26B |
| Q2 2023 | 225 | $1.81B |
| Q1 2023 | 233 | $1.89B |
| Q4 2022 | 244 | $1.69B |
| Q3 2022 | 239 | $2.23B |
| Q2 2022 | 226 | $2.02B |
| Q1 2022 | 228 | $1.84B |
| Q4 2021 | 208 | $1.59B |
| Q3 2021 | 202 | $1.59B |
| Q2 2021 | 199 | $1.77B |
| Q1 2021 | 210 | $1.94B |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Corcept Therapeutics Inc; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| D. E. Shaw & Co., Inc. | 788,064 | $36.5M | 0.05% | −161,079−17.0% | Reduced |
| Invesco Ltd. | 857,358 | $39.7M | 0.01% | +192,001+28.9% | Added |
| Connor, Clark & Lunn Investment Management Ltd. | 859,563 | $39.8M | 0.19% | +143,507+20.0% | Added |
| Northern Trust Corp | 921,387 | $42.6M | 0.01% | −10,821−1.2% | Reduced |
| Charles Schwab Investment Management Inc | 1,026,487 | $47.5M | 0.01% | +53,191+5.5% | Added |
| Jacobs Levy Equity Management, Inc | 1,223,781 | $56.6M | 0.22% | +352,947+40.5% | Added |
| Norges Bank | 1,259,978 | $58.3M | 0.01% | +437,855+53.3% | Added |
| First Trust Advisors LP | 1,318,137 | $61.0M | 0.06% | −203,471−13.4% | Reduced |
| FMR LLC | 1,363,922 | $63.1M | 0.00% | +269,074+24.6% | Added |
| Morgan Stanley | 1,458,495 | $67.5M | 0.00% | +142,916+10.9% | Added |
| Boston Trust Walden Corp | 1,513,975 | $70.1M | 0.49% | −69,924−4.4% | Reduced |
| Arrowstreet Capital, Limited Partnership | 1,580,621 | $73.2M | 0.06% | +97,199+6.6% | Added |
| Geode Capital Management, LLC | 2,378,758 | $110.1M | 0.01% | +99,470+4.4% | Added |
| Novo Holdings A/S | 2,411,362 | $111.6M | 5.54% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 2,532,499 | $117.2M | 0.03% | −143,836−5.4% | Reduced |
| State Street Corp | 3,519,263 | $162.9M | 0.01% | +19,893+0.6% | Added |
| Parallel Advisors, LLC | 3,813,724 | $176.5M | 4.17% | −2,036−0.1% | Reduced |
| Renaissance Technologies LLC | 6,509,002 | $301.2M | 0.45% | −403,569−5.8% | Reduced |
| Ingalls & Snyder LLC | 8,266,756 | $382.6M | 15.01% | +28,650+0.3% | Added |
| Vanguard Group Inc | 10,006,330 | $463.1M | 0.01% | +452,624+4.7% | Added |
| BlackRock, Inc. | 16,050,402 | $742.8M | 0.02% | +16,050,402 | New |
| Checkpoint Capital L.P. | 0 | $0 | 0.00% | −244,750−100.0% | Sold out |
| TownSquare Capital, LLC | 0 | $0 | 0.00% | −135,698−100.0% | Sold out |
| Norden Group LLC | 0 | $0 | 0.00% | −135,326−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −100,615−100.0% | Sold out |
| Raymond James Financial Services Advisors, Inc. | 0 | $0 | 0.00% | −77,593−100.0% | Sold out |
| Milestone Asset Management, LLC | 0 | $0 | 0.00% | −51,599−100.0% | Sold out |
| Mutual Advisors, LLC | 0 | $0 | 0.00% | −34,406−100.0% | Sold out |
| Baird Financial Group, Inc. | 0 | $0 | 0.00% | −35,859−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −31,205−100.0% | Sold out |
| Moloney Securities Asset Management, LLC | 0 | $0 | 0.00% | −27,375−100.0% | Sold out |
| Quantedge Capital Pte Ltd | 0 | $0 | 0.00% | −25,842−100.0% | Sold out |
| Janney Montgomery Scott LLC | 0 | $0 | 0.00% | −24,932−100.0% | Sold out |
| Edgestream Partners, L.P. | 0 | $0 | 0.00% | −23,516−100.0% | Sold out |
| Petrus Trust Company, LTA | 0 | $0 | 0.00% | −21,151−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −20,715−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −20,200−100.0% | Sold out |
| UniSuper Management Pty Ltd | 0 | $0 | 0.00% | −17,536−100.0% | Sold out |
| Arkadios Wealth Advisors | 0 | $0 | 0.00% | −16,224−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −13,189−100.0% | Sold out |
| Atria Wealth Solutions, Inc. | 0 | $0 | 0.00% | −12,610−100.0% | Sold out |
| Corton Capital Inc. | 0 | $0 | 0.00% | −11,682−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −11,346−100.0% | Sold out |
| Atlas Capital Advisors LLC | 0 | $0 | 0.00% | −10,905−100.0% | Sold out |
| EntryPoint Capital, LLC | 0 | $0 | 0.00% | −9,757−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −6,454−100.0% | Sold out |
| GWM Advisors LLC | 0 | $0 | 0.00% | −562−100.0% | Sold out |
| Innealta Capital, LLC | 0 | $0 | 0.00% | −33−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |
| Buckingham Strategic Wealth, LLC | – | – | – | – | Not filed |